Badalona, October 3, 2024 – Archivel Farma, a biotechnology company focused on the development of own products, is glad to announce the opening of a new business line as a...
Read More
A recent non-clinical study has demonstrated the potential of the therapeutic vaccine RUTI® in treating tuberculosis (TB) in mice. RUTI® has demonstrated remarkable efficacy in reducing lung damage and bacterial...
Read More
Today is #WorldTBDay, a day to raise awareness about the devastating impact of #tuberculosis – one of the world’s oldest and deadliest diseases. #YesWeCanEndTB. #Archivelfarma is aligned with WHO goals…
The STRITUVAD (In Silico TRIals for TUberculosis VAccine Development) project has been completed. It has been a great honour for Archivel to be part of this project co-funded by the…
A new clinical trial, CONSTAN-ARG, will test the effectiveness of the #RUTI® vaccine to shorten treatment in #TB patients. #Archivel Farma has designed and set up a phase IIb clinical study called CONSTAN-ARG to…
The Spanish biotech company Archivel Farma has officially begun the clinical trial of its therapeutic vaccine RUTI®, which will be carried out by Clinical Research Network India, a Contract Research…
The clinical trial will be carried out at the Germans Trias i Pujol Hospital in Badalona (Can RUTI), and it will include 300 healthy health professionals in direct contact with…
As of 30th October 2019, Archivel Farma has obtained from the Spanish Health Authority the authorization as Manufacturer for Sterile investigational medicinal products for terminal sterilised operations of Solids and Implants…